Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Stekovic, S; Hofer, SJ; Tripolt, N; Aon, MA; Royer, P; Pein, L; Stadler, JT; Pendl, T; Prietl, B; Url, J; Schroeder, S; Tadic, J; Eisenberg, T; Magnes, C; Stumpe, M; Zuegner, E; Bordag, N; Riedl, R; Schmidt, A; Kolesnik, E; Verheyen, N; Springer, A; Madl, T; Sinner, F; de Cabo, R; Kroemer, G; Obermayer-Pietsch, B; Dengjel, J; Sourij, H; Pieber, TR; Madeo, F.
Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans.
Cell Metab. 2019; 30(3):462-476 Doi: 10.1016/j.cmet.2019.07.016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Bordag Natalie
Kolesnik Ewald
Madl Tobias
Obermayer-Pietsch Barbara
Pein Lukas
Pieber Thomas
Prietl Barbara
Riedl Regina
Schmidt Albrecht
Sinner Frank Michael
Sourij Harald
Springer Anna Maria
Stadler Julia
Tripolt Norbert
Verheyen Nicolas Dominik
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Caloric restriction and intermittent fasting are known to prolong life- and healthspan in model organisms, while their effects on humans are less well studied. In a randomized controlled trial study (ClinicalTrials.gov identifier: NCT02673515), we show that 4 weeks of strict alternate day fasting (ADF) improved markers of general health in healthy, middle-aged humans while causing a 37% calorie reduction on average. No adverse effects occurred even after >6 months. ADF improved cardiovascular markers, reduced fat mass (particularly the trunk fat), improving the fat-to-lean ratio, and increased β-hydroxybutyrate, even on non-fasting days. On fasting days, the pro-aging amino-acid methionine, among others, was periodically depleted, while polyunsaturated fatty acids were elevated. We found reduced levels sICAM-1 (an age-associated inflammatory marker), low-density lipoprotein, and the metabolic regulator triiodothyronine after long-term ADF. These results shed light on the physiological impact of ADF and supports its safety. ADF could eventually become a clinically relevant intervention. Copyright © 2019 Elsevier Inc. All rights reserved.
Find related publications in this database (using NLM MeSH Indexing)
3-Hydroxybutyric Acid - blood
Adult -
Aging - blood
Biomarkers - blood
Body Mass Index -
Caloric Restriction - adverse effects
Energy Intake - physiology
Fasting - adverse effects
Fasting - blood
Fatty Acids, Unsaturated - blood
Female -
Healthy Aging - blood
Healthy Volunteers -
Humans -
Intercellular Adhesion Molecule-1 - blood
Lipoproteins, LDL - blood
Male -
Middle Aged -
Pilot Projects -
Prospective Studies -
Triiodothyronine - blood
Weight Loss -

© Med Uni Graz Impressum